Eli Lilly Halts India Obesity Campaign After CDSCO Flags Indirect Promotion of Mounjaro MD Bureau12 May 2026 9:07 PM ISTHyderabad: Eli Lilly paused its obesity awareness campaign in India after the nation's drugs regulator warned the company it could violate rules...
India's Drug Panel Recommends Wegovy for Metabolic Liver Disease Treatment Susmita Roy10 May 2026 11:45 AM ISTNew Delhi: In a significant development for the treatment of liver diseases linked to obesity and metabolic disorders, the Subject Expert Committee...
Torrent Emerges Early Leader in India's Generic Semaglutide Race with 38% Market Share: Report Susmita Roy9 May 2026 5:23 PM ISTNew Delhi: Ahmedabad-based drug maker Torrent Pharma has emerged as the early frontrunner in India's fast-expanding generic semaglutide market,...
Amazon Pharmacy to Stock Novo Nordisk's Ozempic Pill, Offer Same-Day Delivery Across US sheeba farhat8 May 2026 4:26 PM ISTNew Delhi: Amazon said ​on Thursday its pharmacy will stock Novo Nordisk's Ozempic pill to treat type 2 diabetes at its kiosks and offer same-day...
The GLP-1 paradox: Rice study finds weight loss drugs may carry unexpected stigma Dr. Kamal Kant Kohli6 May 2026 10:00 AM ISTGlucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity headlines to everyday...
Novo Nordisk, Eli Lilly Penalised in France for Indirect Promotion of Obesity Drugs sheeba farhat5 May 2026 7:03 PM ISTParis: France's medicine safety agency ANSM said Monday it had imposed fines on pharmaceutical firms Novo Nordisk and Eli Lilly over their advertising...
Eli Lilly's Foundayo Sees Slow Start in U.S., Trails Novo Nordisk's Wegovy in Early Prescription Race sheeba farhat2 May 2026 10:00 AM ISTBengaluru: Eli Lilly's newly launched oral weight-loss drug, Foundayo, was prescribed 5,612 times in the U.S. in the third week after its launch,...
USFDA Says No Clinical Need to Compound GLP-1 Drugs, Novo Nordisk, Eli Lilly Stocks Jump sheeba farhat1 May 2026 10:00 AM ISTNew York: The U.S. Food and Drug Administration (USFDA) on ​Thursday proposed excluding Novo Nordisk and Eli Lilly's weight-loss drugs from a key...
Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry sheeba farhat25 April 2026 5:06 PM ISTNew Delhi: Swiss ‌drugmaker Roche's first-quarter sales dropped by 5%, it said on Thursday, citing unfavourable foreign exchange effects that offset...
Lilly's Foundayo Clocks 1,390 Prescriptions in Debut Week as Oral Obesity Drug Race Heats Up sheeba farhat19 April 2026 12:09 PM ISTNew Delhi: Eli Lilly's newly launched weight-loss pill was prescribed 1,390 ‌times in the U.S. in its first week of sales, according to analysts who...
AI Meets Pharma: Novo Nordisk Teams Up with OpenAI for Faster Drug Innovation sheeba farhat15 April 2026 7:00 PM ISTNew Delhi: Danish pharmaceuticals group Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, announced Tuesday a "strategic...
USFDA Approves Eli Lilly's Weight-Loss Pill Foundayo, Intensifies Rivalry with Novo Nordisk sheeba farhat3 April 2026 2:49 PM ISTWashington: The U.S. FDA on Wednesday approved Eli Lilly's weight-loss pill, setting up the next battle with Novo Nordisk for the millions of...
